Literature DB >> 24702703

Myasthenia gravis onset during rheumatic disease: a new paradoxical effect of anti-TNF alpha therapy?

Vincenzo Bruzzese1, Cinzia Marrese, Palma Scolieri, Cesare Hassan, Roberto Lorenzetti, Angelo Zullo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24702703     DOI： 10.1111/1756-185X.12340

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  4 in total

Review 1.  Don't forget astrocytes when targeting Alzheimer's disease.

Authors:  Jessica S Sadick; Shane A Liddelow
Journal:  Br J Pharmacol       Date:  2019-02-19       Impact factor: 8.739

Review 2.  CNS Demyelination with TNF-α Blockers.

Authors:  Elissavet Kemanetzoglou; Elisabeth Andreadou
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 3.  Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.

Authors:  Riccardo Bixio; Davide Bertelle; Francesca Pistillo; Elisa Pedrollo; Antonio Carletto; Maurizio Rossini; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2022-01-14       Impact factor: 2.980

Review 4.  Neurological Complications of Biological Treatment of Psoriasis.

Authors:  Mateusz Kamil Ożóg; Beniamin Oskar Grabarek; Magdalena Wierzbik-Strońska; Magdalena Świder
Journal:  Life (Basel)       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.